U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core Biopsy, Surgical Biopsy, Skin Biopsy/Punch Biopsy, Others), By Cause (Application), By Site (Organ), And Segment Forecasts, 2025 - 2030

Market Segmentation

• U.S. Cancer Biopsy Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Fine-needle Aspiration
    • Pharma-use
    • Clinical
  • Core Biopsy
    • Pharma-use
    • Clinical
  • Surgical Biopsy
    • Pharma-use
    • Clinical
  • Skin Biopsy /Punch Biopsy
    • Pharma-use
    • Clinical
  • Others
    • Pharma-use
    • Clinical
• U.S. Cancer Biopsy Cause (Application) Outlook (Revenue, USD Billion, 2018 - 2030)
  • Screening & Monitoring
  • Diagnostics
  • Investigational & Translational Research
  • Pharma & Biopharma Discovery & Development
• U.S. Cancer Biopsy Site (Organ) Outlook (Revenue, USD Billion, 2018 - 2030)
  • Liver
  • Breast
  • Thyroid
  • Prostate Gland
  • Uterus & Cervix
  • Kidney
  • Bladder
  • Lungs
  • Pancreas
  • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance